Publications

5674 Results

Reduced Risk of Prostate Cancer With 5a-Reductase Inhibitors. [Editorial]

Authors
IM Thompson;P Goodman;C Tangen
Journal / Conference
Journal of the National Cancer Institute Nov 1;110(11):1159-1160; Mar 14. doi: 10.1093/jnci/djy038. [Epub ahead of print]
Year
2018
Research Committee(s)
Cancer Control
PMID
PMID29547919
PMC
PMCIDPMC6454440
Study Number(s)
SWOG-9217

Chemoprevention in Prostate Cancer: Current Perspective and Future Directions [Review]

Authors
J Rivero;IM Thompson;M Liss;D Kaushik
Journal / Conference
Cold Spring Harbor Perspectives in Medicine Oct 1;8(10); 2018 Jan 8 [Epub ahead of print]
Year
2018
Research Committee(s)
Cancer Control
PMID
PMID29311128
PMC
PMC6169981
Study Number(s)
SWOG-9217

The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401)

Authors
J Ligibel;W Barry;C Alfano;D Hershman;M Irwin;M Neuhouser;C Thomson;L Delahanty;E Frank;P Spears;E Paskett;JO Hopkins;V Bernstein;V Stearns;JR White;T Wadden;PJ Goodwin;L Carey;A Partridge;E Winer
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr TPS598); ASCO Annual Meeting (June 1-5, 2018, Chicago), poster
Year
2018
Research Committee(s)
Breast
Study Number(s)
CTSU/A011401

Low free testosterone and prostate cancer risk: a collaborative analysis of 20 prospective studies

Authors
EL Watts;P Appelby;A Perez-Cornago;H Bas Bueno-de-Mesquita;J Chan;C Chen;al et
Journal / Conference
European Urology Nov;74(5):585-594; Aug 1 [Epub ahead of print]
Year
2018
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID30077399
PMC
PMC6195673
Study Number(s)
SWOG-9217

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials

Authors
S Ailawadhi;S Jacobus;R Sexton;A Stewart;A Dispenzieri;M Hussein;JA Zonder;J Crowley;A Hoering;B Barlogie;R Orlowski;S Rajkumar
Journal / Conference
Blood Cancer Journal, Jul 6;8(7):67
Year
2018
Research Committee(s)
Cancer Survivorship and Myeloma
PMID
PMID29980678
PMC
PMC6035273
Study Number(s)
S0204, S0232, SWOG-9321

Value of Anti-Cancer Drugs in SWOG Phase III Clinical Trials: Evidence from Multiple Evaluation Mechanisms

Authors
V Nghiem;R Vaidya;M Banegas;D Hershman;J Unger
Journal / Conference
AcademyHealth Annual Research Meeting (June 23-26, 2018, Seattle, WA), poster #B-335
Year
2018
Research Committee(s)
Breast, Cancer Care Delivery, Gastrointestinal, Genitourinary, Gynecologic, Leukemia, Lung, Lymphoma, Melanoma, and Myeloma
Study Number(s)
S0003, S0008, S0012, S0106, S0124, S0200, S0205, S0226, S0232, S0421, SWOG-8501 (INT-0051), SWOG-8612, SWOG-8691 (INT-0073), SWOG-8692 (INT-0075), SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891), SWOG-8794, SWOG-8795 (INT-0094) (EST-1888), SWOG-8812, SWOG-8814, SWOG-8894 (INT-0105) (EST-2889), SWOG-8949, SWOG-9028, SWOG-9031, SWOG-9032, SWOG-9133, SWOG-9210, SWOG-9308, SWOG-9313, SWOG-9321, SWOG-9333, SWOG-9346, SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415), SWOG-9420, SWOG-9509, S9623, S9701, S9916

Survival by Hispanic Ethnicity Among Cancer Patients participating in SWOG Clinical Trials

Authors
A Moseley;M Chavez-MacGregor;J Unger;S Ramsey;D Hershman
Journal / Conference
Society for Clinical Trials Annual Meeting (May 20-23 2018, Portland, OR), oral presentation
Year
2018
Research Committee(s)
Breast, Gastrointestinal, Genitourinary, Leukemia, Lung, Lymphoma, Myeloma, and Sarcoma
Study Number(s)
S0003, S0012, S0016, S0033, S0106, S0221, S0226, S0232, S0307, S0421, S0500, SWOG-8516 (INT-0067), SWOG-8600, SWOG-8809, SWOG-8814, SWOG-8894 (INT-0105) (EST-2889), SWOG-8897, SWOG-8905, SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195), SWOG-9031, SWOG-9125, SWOG-9210, SWOG-9240, SWOG-9304 (INT-0144), SWOG-9308, SWOG-9313, SWOG-9321, SWOG-9333, SWOG-9346

Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension

Authors
M Li;F Mulkey;C Jiang;B O'Neil;B Schneider;F Shen;P Friedman;Y Momozawa;M Kubo;D Niedzwiecki;H Hochster;H-J Lenz;JN Atkins;H Rugo;S Halabi;W Kelly;H McLeod;F Innocenti;M Retain;A Venook;K Owzar;D Kroetz
Journal / Conference
Clinical Cancer Research Oct 1;24(19):4734-4744
Year
2018
Research Committee(s)
Gastrointestinal
PMID
PMID29871907
PMC
PMC6168379
Study Number(s)
CTSU/C80405

In Search of an Oncogene Driver for Squamous Lung Cancer [Invited Commentary]

Authors
D Gandara;J Reiss;PN Lara
Journal / Conference
JAMA Oncology Sep 1;4(9):1197-1198; Jun 14 [Epub ahead of print]
Year
2018
Research Committee(s)
Lung
PMID
PMID29902311
PMC
n/a - commentary
Study Number(s)
S1400B, S1400C, S1400D

CALBG 50604: Risk-Adapted Treatment of Non-Bulky Early Stage Hodgkin Lymphoma based on Interim PET

Authors
DJ Straus;S Jung;B Pitcher;L Kostakoglu;J Grecula;E Hsi;H Schoder;L Popplewell;J Chang;CH Moskowitz;N Wagner-Johnson;JP Leonard;JW Friedberg;BS Kahl;BD Cheson;N Bartlett
Journal / Conference
Blood Sep 6;132(10):1013-1021; Jul 26 [Epub ahead of print]
Year
2018
Research Committee(s)
Lymphoma
PMID
PMID30049811
PMC
PMC6128083